Skip to main content
. 2020 Mar 14;12(3):e7269. doi: 10.7759/cureus.7269

Figure 1. Patient and tumour characteristics of patients selected for Oncotype DX testing compared to patients not genetically profiled.

Figure 1

A) Mean age of patients in the ODX and non-ODX groups (Mann-Whitney, P<0.0001); B) percentage of patients in the ODX and non-ODX groups with symptomatic presentation or identification of cancer through national screening (chi-squared, P<0.0001); C) median tumour size (cm) of tumours for patients in the ODX and non-ODX groups (Mann-Whitney, P<0.001); and D) percentage of tumours classified as Grade 1, 2, or 3 for patients in the ODX and non-ODX groups (chi-squared, P<0.0001); ODX group, patients with cancers that were genetically profiled through Oncotype DX testing; non-ODX group, patients that did not have Oncotype DX testing.